Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 04 04:00PM ET
2.95
Dollar change
+0.26
Percentage change
9.67
%
Index- P/E- EPS (ttm)-47.92 Insider Own1.45% Shs Outstand1.15M Perf Week48.99%
Market Cap3.39M Forward P/E- EPS next Y- Insider Trans81.74% Shs Float1.13M Perf Month37.21%
Income-8.88M PEG- EPS next Q- Inst Own0.54% Short Float1.57% Perf Quarter6.50%
Sales0.00M P/S- EPS this Y- Inst Trans21.08% Short Ratio0.02 Perf Half Y-46.56%
Book/sh6.11 P/B0.48 EPS next Y- ROA-138.06% Short Interest0.02M Perf Year-94.92%
Cash/sh6.87 P/C0.43 EPS next 5Y- ROE-181.81% 52W Range1.84 - 101.25 Perf YTD-61.36%
Dividend Est.- P/FCF- EPS past 5Y-17.82% ROI-132.58% 52W High-97.09% Beta1.44
Dividend TTM- Quick Ratio5.24 Sales past 5Y0.00% Gross Margin- 52W Low60.76% ATR (14)0.54
Dividend Ex-Date- Current Ratio5.24 EPS Y/Y TTM82.44% Oper. Margin0.00% RSI (14)59.57 Volatility38.30% 17.54%
Employees2 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price1875.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q95.88% Payout- Rel Volume0.20 Prev Close2.69
Sales Surprise- EPS Surprise91.20% Sales Q/Q- Earnings- Avg Volume1.00M Price2.95
SMA2030.61% SMA5016.27% SMA200-31.83% Trades Volume200,533 Change9.67%
Nov-04-24 09:00AM
Oct-30-24 08:00AM
Oct-28-24 09:00AM
Oct-25-24 08:00AM
Sep-30-24 07:00AM
07:00AM Loading…
Sep-16-24 07:00AM
Jul-22-24 08:30AM
Jul-17-24 08:30AM
Jul-16-24 08:30AM
Jun-10-24 08:00AM
May-29-24 08:30AM
May-24-24 08:12AM
07:16AM
May-22-24 07:00AM
May-09-24 01:55PM
02:33PM Loading…
May-02-24 02:33PM
Apr-30-24 08:31AM
Apr-29-24 09:00AM
Apr-23-24 07:31AM
Apr-15-24 08:31AM
Mar-06-24 07:00AM
Mar-05-24 08:31AM
07:00AM
Feb-20-24 08:01AM
Feb-05-24 08:30AM
Jan-29-24 08:00AM
Dec-11-23 08:01AM
Nov-30-23 04:01PM
09:45AM
Nov-28-23 08:43AM
09:40PM Loading…
Nov-27-23 09:40PM
08:00AM
Nov-20-23 09:27AM
Nov-17-23 07:00AM
Nov-07-23 08:20AM
Nov-06-23 05:35PM
Sep-22-23 08:30AM
Sep-21-23 09:35AM
Sep-11-23 11:51AM
Sep-08-23 02:30PM
Aug-15-23 10:20AM
Aug-09-23 08:47AM
Jul-20-23 08:00AM
Jul-10-23 08:47AM
Jul-06-23 08:30AM
May-15-23 08:47AM
May-09-23 07:15AM
May-02-23 04:05PM
08:47AM
Apr-27-23 09:50PM
04:00PM
Apr-13-23 08:47AM
Apr-12-23 10:30AM
Apr-10-23 08:47AM
Mar-28-23 08:47AM
Feb-28-23 09:45AM
Feb-15-23 07:11AM
Feb-13-23 04:15PM
07:11AM
Feb-10-23 07:17AM
Feb-08-23 07:11AM
Feb-06-23 07:00AM
Jan-31-23 10:41AM
07:11AM
Jan-17-23 11:29AM
10:00AM
Dec-12-22 05:39AM
Dec-01-22 08:47AM
Nov-22-22 06:30AM
Oct-18-22 08:47AM
Oct-06-22 08:47AM
Sep-14-22 08:47AM
Jul-08-22 08:17AM
Jul-04-22 03:35PM
Jun-27-22 08:27AM
Jun-13-22 09:06AM
08:00AM
Jun-02-22 08:47AM
May-05-22 08:47AM
Mar-02-22 08:37AM
Feb-16-22 09:40AM
Feb-14-22 09:04AM
Feb-11-22 07:15AM
Feb-01-22 09:40AM
Jan-26-22 08:30AM
Jan-14-22 04:00PM
Jan-13-22 11:05AM
Jan-11-22 07:55PM
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILBY RANDYCEOOct 08 '24Buy2.092,5005,22112,934Oct 10 04:15 PM
Appajosyula SireeshChief Operating OfficerOct 08 '24Buy1.935,0009,65016,364Oct 08 04:10 PM
MILBY RANDYCEODec 15 '23Buy0.5029,00014,587156,517Dec 18 10:04 AM
MILBY RANDYCEONov 30 '23Buy1.0010,00010,000127,517Dec 04 04:15 PM